Combined pharmacological preconditioning with a G-protein-coupled receptor agonist, a mitochondrial KATP channel opener and a nitric oxide donor mimics ischaemic preconditioning

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 9, 2003, Pages 684-693

  Otani, Hajime ^a   Okada, Takayuki ^a   Fujiwara, Hiroyoshi ^a   Uchiyama, Takamichi ^a   Sumida, Tomohiko ^a   Kido, Masakuni ^a   Imamura, Hiroji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Diazoxide; Ischaemic preconditioning; Pharmacological preconditioning; Protein kinase C

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 5 HYDROXYDECANOIC ACID; ADENOSINE; CHELERYTHRINE; DIAZOXIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PERTUSSIS TOXIN; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN KINASE C EPSILON; RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PHOSPHORYLATION; RAT; STATISTICAL ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA, HEART; NITRIC OXIDE DONORS; POTASSIUM CHANNELS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 0141484401     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03896.x     Document Type: Article

References (51)

1. Higgins TL, Estafanous FG, Loop FD et al. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann. Thorac. Surg. 1997; 64: 1050-8.
2. Yellon DM, Dana A. The preconditioning phenomenon. A tool for the scientist or a clinical reality? Circ. Res. 2000; 87: 543-50.
3. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
4. Toombs CF, McGee S, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992; 86: 986-94.
5. Pain T, Yang XM, Critz SD et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ. Res. 2000; 87: 460-6.
6. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J. Mol. Cell. Cardiol. 2000; 32: 1159-67.
7. Lochner A, Marais E, Genade S, Moolman JA. Nitric oxide. A trigger for classic preconditioning? Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H2752-65.
8. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ. Res. 2001; 89: 273-8.
9. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659-65.
10. Cave AC, Collis CS, Downey JM, Hearse DJ. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc. Res. 1993; 27: 663-8.
11. ATP channels. Am. J. Physiol. 1997; 272: H334-42.
12. Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasche P. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann. Thorac. Surg. 2000; 70: 590-4.
13. Toyoda Y, Di Gregorio V, Parker RA, Levitsky S, McCully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 2000; 102 (Suppl.): III-326-31.
14. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors. Am. J. Physiol. Heart Circ. Physiol. 2002; 282: H1933-43.
15. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ. Res. 2001; 88: 802-9.
16. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell. Cardiol. 1997; 29: 207-16.
17. Wang D, Yu X, Cohen RA, Brecher P. Distinct effects of N-acetylcysteine and nitric oxide on angiotensin II-induced epidermal growth factor receptor phosphorylation and intracellular Ca(2+) levels. J. Biol. Chem. 2000; 275: 12 223-30.
18. Hattori R, Otani H, Uchiyama T et al. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2001; 281: H1066-74.
19. Ping P, Zhang J, Pierce Jr WM, Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ. Res. 2001; 88: 59-62.
20. Gray MO, Karliner JS, Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 1997; 272: 30 945-51.
21. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 1999; 31: 1937-48.
22. Lu K, Otani H, Yamamura T et al. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. J. Thorac. Cardiovasc. Surg. 2001; 121: 137-48.
23. Ravingerova T, Pyne NJ, Parratt JR. Ischaemic preconditioning in the rat heart. The role of G-proteins and adrenergic stimulation. Mol. Cell. Biochem. 1995; 147: 123-8.
24. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: Player or spectator? Circ. Res. 1996; 79: 627-30.
25. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: A critical review. Cardiovasc. Res. 1998; 40: 9-22.
26. Takano H, Tang XL, Bolli R. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H2350-9.
27. Baines CP, Cohen MV, Downey JM. Signal transduction in ischemic preconditioning. The role of kinases and mitochondrial K(ATP) channels. J. Cardiovasc. Electrophysiol. 1999; 10: 741-54.
28. Parsons M, Young L, Lee JE, Jacobson KA, Liang BT. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J. 2000; 14: 1423-31.
29. Murga C, Fukuhara S, Gutkind JS. A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt. J. Biol. Chem. 2000; 275: 12 069-73.
30. Souroujon MC, Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat. Biotechnol. 1998; 16: 919-24.
31. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ. Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J. Biol. Chem. 1999; 274: 34 758-64.
32. Borner C, Eppenberger U, Wyss R, Fabbro D. Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters. Proc. Natl Acad. Sci. USA 1988; 85: 2110-14.
33. Pears C, Stabel S, Cazaubon S, Parker PJ. Studies on the phosphorylation of protein kinase C-alpha. Biochem. J. 1992; 283: 515-18.
34. Bornancin F, Parker PJ. Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 1997; 272: 3544-9.
35. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J. 2000; 19: 496-503.
36. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A. Regulation of novel protein kinase C epsilon by phosphorylation. Biochem. J. 2002; 363: 537-45.
37. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ. Res. 2000; 87: 309-15.
38. Du G, Altshuller YM, Kim Y et al. Dual requirement for rho and protein kinase C in direct activation of phospholipase DI through G protein-coupled receptor signaling. Mol. Biol. Cell 2000; 11: 4359-68.
39. Cohen MV, Liu Y, Liu GS et al. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 1996; 94: 1713-18.
40. Eskildsen-Helmond YE, Bezstarosti K, Dekkers DH, van Heugten HA, Lamers JM. Cross-talk between receptor-mediated phospholipase C-beta and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes. J. Mol. Cell. Cardiol. 1997; 29: 2545-59.
41. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J. Mol. Cell. Cardiol. 2001; 33: 1897-918.
42. Balafanova Z, Bolli R, Zhang J et al. Nitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon-RACK2 interactions: A novel mechanism of no-triggered activation of PKCepsilon. J. Biol. Chem. 2002; 277: 15 021-7.
43. Klann E, Roberson ED, Knapp LT, Sweatt JD. A role for superoxide in protein kinase C activation and induction of long-term potentiation. J. Biol. Chem. 1998; 273: 4516-22.
44. Vondriska TM, Zhang J, Song C et al. Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: Complex formation as a means for cardioprotective signaling. Circ. Res. 2001; 88: 1306-13.
45. Ping P, Song C, Zhang J et al. Formation of protein kinase C (epsilon)-Lck signaling modules confers cardioprotection. J. Clin. Invest. 2002; 109: 499-507.
46. MacMillan-Crow LA, Greendorfer JS, Vickers SM, Thompson JA. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch. Biochem. Biophys. 2000; 377: 350-6.
47. Di Stasi AM, Mallozzi C, Macchia G, Petrucci TC, Minetti M. Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins. J. Neurochem. 1999; 73: 727-35.
48. Wang Y, Hirai K, Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ. Res. 1999; 85: 731-41.
49. Ohnuma Y, Miura T, Miki T et al. Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H440-7.
50. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. Complementary role of extracellular ATP and adenosine in ischemic preconditioning in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 2002; 282: H1810-20.
51. Wang S, Cone J, Liu Y. Dual roles of mitochondrial K(ATP) channels in diazoxide-mediated protection in isolated rabbit hearts. Am. J. Physiol. Heart Circ. Physiol. 2001; 280: H246-55.